Core Catalyst Pilot Award
Internal — Columbia University Irving Medical Center only
The Core Catalyst Pilot Award from Columbia University Irving Medical Center funds innovative biospecimen-based research using advanced core facilities to accelerate scientific discovery and clinical advances.
Funder: Columbia University Irving Medical Center
Due Dates: October 13, 2026
Funding Amounts: $50,000 per award; project period: December 15, 2026 – May 31, 2027
Summary: Supports innovative translational and clinical research using CUIMC core facilities to accelerate biospecimen analysis and scientific discovery.
Description
The Core Catalyst Pilot Award provides rapid funding to support the use of Columbia University Irving Medical Center’s (CUIMC) advanced core facilities for innovative translational and clinical research. This award emphasizes projects that leverage institutional or departmental core resources—such as the Irving Institute’s Biomarkers Core Laboratory—to enable comprehensive analysis of pre-clinical or clinical biospecimens. The goal is to generate new data, accelerate scientific discovery, and catalyze future breakthroughs in patient care and health, even for investigators without dedicated laboratory infrastructure.
